SOPH (NASDAQ: SOPH) insider schedules 22,000-share sale under 10b5-1 plan

Rhea-AI Filing Summary

SOPH reports a planned sale of 22,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $147,180.00. The planned sale includes 2,000 shares from an 08/07/2026 Exercise of Stock Options and 20,000 Founders Shares originally dated 06/20/2012. Recent activity shows multiple Rule 10b5-1 sales by Zhenyu Xu between May and August 2026.

Key Figures

Shares to be sold: 22,000 shares Aggregate market value of planned sale: $147,180.00 Shares outstanding: 85,127,825 shares +3 more

6 metrics

Shares to be sold 22,000 shares Planned sale of SOPH common stock reported in Form 144

Aggregate market value of planned sale $147,180.00 Total market value for 22,000 SOPH shares to be sold

Shares outstanding 85,127,825 shares SOPH common shares outstanding as reported in the form

10b5-1 sale on 08/05/2026 3,000 shares for $21,012.90 Rule 10b5-1 sale of SOPH common stock by Zhenyu Xu

10b5-1 sale on 08/04/2026 10,000 shares for $69,168.00 Rule 10b5-1 sale of SOPH common stock by Zhenyu Xu

10b5-1 sale on 07/06/2026 7,393 shares for $38,241.77 Rule 10b5-1 sale of SOPH common stock by Zhenyu Xu

Key Terms

Exercise of Stock Options, Founders Shares, 10b5-1 Sales

3 terms

Exercise of Stock Options financial

"Common | 08/07/2026 | Exercise of Stock Options | Issuer"

Founders Shares financial

"Common | 06/20/2012 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

10b5-1 Sales regulatory

"10b5-1 Sales for ZHENYU XU | Common | 08/05/2026"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:35 PM Accepted by SEC EDGAR 08/07/2026 - 04:35 PM Learn about SEC filing dates

FAQ

What share sale is disclosed for SOPH in this Form 144?

The filing discloses a planned sale of 22,000 shares of SOPH common stock with an aggregate market value of $147,180.00, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many SOPH shares come from option exercises versus founders shares?

The planned 22,000-share sale comprises 2,000 shares from an Exercise of Stock Options dated 08/07/2026 and 20,000 Founders Shares originally dated 06/20/2012, both indicated as issued by the company.

What recent 10b5-1 sales by Zhenyu Xu in SOPH are reported?

Reported Rule 10b5-1 sales by Zhenyu Xu include 3,000 shares on 08/05/2026 for $21,012.90 and 10,000 shares on 08/04/2026 for $69,168.00, among several transactions from May to July 2026.

What SOPH trading history over the past 3 months is included?

The filing lists multiple common stock sales, such as 7,393 shares on 07/06/2026 for $38,241.77 and 4,000 shares on 06/15/2026 for $20,056.40, all identified as 10b5-1 Sales for Zhenyu Xu.

How many SOPH shares were sold in the earliest transaction listed?

The earliest transaction listed shows a sale of 4,000 shares of SOPH common stock on 05/13/2026 for total proceeds of $18,168.40, labeled as a Rule 10b5-1 sale for Zhenyu Xu.

What does the Form 144 say about SOPH shares outstanding?

The Form 144 reports 85,127,825 shares of SOPH common stock outstanding, providing context for the planned 22,000-share sale disclosed in the same filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22000	147180.00	85127825	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/07/2026	Exercise of Stock Options	Issuer			2000	08/07/2026	Cash
Common	06/20/2012	Founders Shares	Issuer			20000	06/20/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	08/05/2026	3000	21012.90
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	08/04/2026	10000	69168.00
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/13/2026	4000	22819.20
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	7393	38241.77
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	06/15/2026	4000	20056.40
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	608	2797.71
10b5-1 Sales for ZHENYU XU La Piece 12 ch-1180 Rolle V8 00000	Common	05/13/2026	4000	18168.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)